A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial of Lisofylline in Patients with Acute Lung Injury and Adult Respiratory Distress Syndrome (LARMA)
This study was a randomized, double-blind, placebo- controlled multi-center 2 x 2 factorial study. Each patient is randomized between Lisofylline and Placebo.